Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Teladoc Health, Inc.
TDOC
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $1.6B
$9.15
▲ +0.49%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$4.40 - $9.77
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 9.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Integrated multi-brand platform (Teladoc, Livongo, BetterHelp) serving diverse healthcare needs
- Established relationships with major employers, health plans, and health systems representing millions of members
- Proprietary data analytics and AI-driven insights for personalized chronic disease management
- Regulatory expertise and compliance infrastructure across multiple healthcare verticals
- Scalable technology platform with network effects and switching costs
Bear Case
1 risk
- High volatility (beta 2.1). Larger-than-normal price swings expected.
Growth
Stable outlook
Premium gross margins (70%)
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Hot
+72.7% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying TDOC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 28, 2026
APR 29, 2026
Reported EPS of -$0.36 vs -$0.35 consensus (-4.2% surprise). Revenue of $613.8M vs $611.0M expected (+0.5%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-4.2%
Next: Apr 28, 2026
Revenue trend · last 8Q
—
—
-3%
-3%
-2%
-2%
+0%
-2%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$642.4M
$640.5M
$640.5M
$629.4M
$631.9M
$626.4M
$642.3M
$613.8M
Margins · last 8Q
Gross
—
Operating
—
Profit
-10.4%
Wall Street consensus
13 analysts · 31% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
31%
Hold
69%
Sell
0%
Median Price Target
$6.00
▼ -34.4% vs $9.15
Latest: Citi · May 5, 2026
1 analyst covering